$SXTC
China SXT Pharmaceuticals, Inc. Stock $sxtc

$sxtc Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 20-F Financial Statement

#000121390024068266 Filed on August 13, 2024

Income Statement

Concept	2024 Q1	2024	2023 Q1
Revenue	$988.9K	$1.928M	$763.4K
YoY Change	29.54%	-2.19%	-51.52%
Cost Of Revenue	$723.3K	$1.375M	$426.8K
YoY Change	69.47%	-11.06%	-34.03%
Gross Profit	$265.6K	$554.0K	$336.6K
YoY Change	-21.08%	29.96%	-63.72%
Gross Profit Margin	26.86%	28.73%	44.09%
Selling, General & Admin	-$6.568M	$3.069M	$4.794M
YoY Change	-237.02%	-49.13%	48.6%
% of Gross Profit	-2472.68%	554.03%	1424.18%
Research & Development		$184.2K
YoY Change		-8.23%
% of Gross Profit		33.25%
Depreciation & Amortization	$100.5K	$203.2K	$140.2K
YoY Change	-28.31%	-18.75%	4.61%
% of Gross Profit	37.83%	36.69%	41.65%
Operating Expenses	-$6.568M	$3.069M	$4.794M
YoY Change	-237.02%	-49.13%	48.6%
Operating Profit	$6.834M	-$2.515M	-$4.457M
YoY Change	-253.33%	-55.15%	93.94%
Interest Expense	-$207.8K	-$544.3K	-$92.49K
YoY Change	124.63%	-214.16%	151.54%
% of Operating Profit	-3.04%
Other Income/Expense, Net	-$28.42K	-$583.3K	$109.4K
YoY Change	-125.98%	78.24%	-135.63%
Pretax Income	$6.598M	-$3.099M	-$4.440M
YoY Change	-248.59%	-47.79%	68.07%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	$6.598M	-$3.099M	-$4.440M
YoY Change	-248.59%	-47.79%	67.92%
Net Earnings / Revenue	667.16%	-160.67%	-581.64%
Basic Earnings Per Share		-$3.57
Diluted Earnings Per Share	$5.35	-$3.57	-$0.41
COMMON SHARES
Basic Shares Outstanding	0.000 shares	867.4K shares	11.43M shares
Diluted Shares Outstanding		867.4K shares

Balance Sheet

Concept	2024 Q1	2024	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.07M	$12.07M	$17.37M
YoY Change	-30.5%	-30.5%	11.88%
Cash & Equivalents	$12.07M	$12.07M	$17.37M
Short-Term Investments
Other Short-Term Assets	$21.74K	$21.74K	$276.9K
YoY Change	-92.15%	-92.15%	-27.98%
Inventory	$794.9K	$794.9K	$531.3K
Prepaid Expenses
Receivables	$1.315M	$845.9K	$1.345M
Other Receivables	$83.63K	$500.5K	$230.6K
Total Short-Term Assets	$14.23M	$14.23M	$19.52M
YoY Change	-27.09%	-27.09%	-13.05%
LONG-TERM ASSETS
Property, Plant & Equipment	$328.8K	$564.7K	$962.2K
YoY Change	-65.82%	-55.48%	-39.52%
Goodwill
YoY Change
Intangibles	$19.10K		$27.87K
YoY Change	-31.46%
Long-Term Investments
YoY Change
Other Assets	$8.310M	$8.310M	$8.737M
YoY Change	-4.88%	-4.88%	-7.69%
Total Long-Term Assets	$8.894M	$8.894M	$10.03M
YoY Change	-11.35%	-11.35%	-9.57%
TOTAL ASSETS
Total Short-Term Assets	$14.23M	$14.23M	$19.52M
Total Long-Term Assets	$8.894M	$8.894M	$10.03M
Total Assets	$23.13M	$23.13M	$29.55M
YoY Change	-21.75%	-21.75%	-11.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.280M	$1.280M	$1.378M
YoY Change	-7.14%	-7.14%	-7.04%
Accrued Expenses	$1.498M	$1.498M	$1.120M
YoY Change	33.81%	33.81%	15.46%
Deferred Revenue	$187.7K		$165.5K
YoY Change	13.37%
Short-Term Debt	$493.1K	$493.1K	$167.5K
YoY Change	194.44%	194.45%
Long-Term Debt Due	$21.33K	$1.801M	$7.863K
YoY Change	171.26%	-43.09%	-99.62%
Total Short-Term Liabilities	$8.902M	$8.902M	$14.50M
YoY Change	-38.59%	-38.59%	-15.33%
LONG-TERM LIABILITIES
Long-Term Debt	$117.1K	$117.1K	$117.9K
YoY Change	-0.62%	-0.62%
Other Long-Term Liabilities	$177.5K	$177.5K	$248.0K
YoY Change	-28.4%	-28.4%
Total Long-Term Liabilities	$294.7K	$294.7K	$365.8K
YoY Change	-19.45%	-19.45%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.902M	$8.902M	$14.50M
Total Long-Term Liabilities	$294.7K	$294.7K	$365.8K
Total Liabilities	$9.197M	$9.197M	$14.86M
YoY Change	-38.12%	-38.12%	-13.19%
SHAREHOLDERS EQUITY
Retained Earnings	-$24.71M		-$21.61M
YoY Change	14.34%		37.77%
Common Stock	$39.67M		$913.8K
YoY Change	4241.05%		462.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$13.93M	$13.93M	$14.69M
YoY Change
Total Liabilities & Shareholders Equity	$23.13M	$23.13M	$29.55M
YoY Change	-21.75%	-21.75%	-11.9%

Cashflow Statement

Concept	2024 Q1	2024	2023 Q1
OPERATING ACTIVITIES
Net Income	$6.598M	-$3.099M	-$4.440M
YoY Change	-248.59%	-47.79%	67.92%
Depreciation, Depletion And Amortization	$100.5K	$203.2K	$140.2K
YoY Change	-28.31%	-18.75%	4.61%
Cash From Operating Activities	-$1.348M	-$1.928M	$468.4K
YoY Change	-387.91%	2287.47%	-19.34%
INVESTING ACTIVITIES
Capital Expenditures	$7.060K	$7.060K	$50.56K
YoY Change	-86.04%	-90.01%	-222.27%
Acquisitions
YoY Change
Other Investing Activities	$13.85K	$33.49K	-$1.050K
YoY Change	-1419.05%	-42.63%	-100.01%
Cash From Investing Activities	$6.780K	$26.42K	-$51.61K
YoY Change	-113.14%	-314.77%	-100.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.837M	-$2.624M	14.01M
YoY Change	-86.89%	-189.22%	154.53%
NET CHANGE
Cash From Operating Activities	-1.348M	-$1.928M	468.4K
Cash From Investing Activities	6.780K	$26.42K	-51.61K
Cash From Financing Activities	1.837M	-$2.624M	14.01M
Net Change In Cash	495.6K	-$5.291M	14.43M
YoY Change	-96.56%	-394.15%	-5.95%
FREE CASH FLOW
Cash From Operating Activities	-$1.348M	-$1.928M	$468.4K
Capital Expenditures	$7.060K	$7.060K	$50.56K
Free Cash Flow	-$1.356M	-$1.935M	$417.8K
YoY Change	-424.44%	1177.83%	-32.83%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	913785	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	266973	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41591	shares
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	117862	usd
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	294667	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	365823	usd
CY2024Q1	us-gaap	Liabilities Liabilities	9196611	usd
CY2023Q1	us-gaap	Liabilities Liabilities	14862761	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	2
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	2
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2218206	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2218206	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	457365	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	457365	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	4352290	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	35315616	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	35588214	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24711665	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-21613133	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1025795	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-197571	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	13930446	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	14691295	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23127057	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	29554056	usd
CY2024	us-gaap	Revenues Revenues	1928497	usd
CY2023	us-gaap	Revenues Revenues	1971679	usd
CY2022	us-gaap	Revenues Revenues	2602281	usd
CY2024	us-gaap	Cost Of Revenue CostOfRevenue	1374526	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	1545408	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	1350638	usd
CY2024	us-gaap	Gross Profit GrossProfit	553971	usd
CY2023	us-gaap	Gross Profit GrossProfit	426271	usd
CY2022	us-gaap	Gross Profit GrossProfit	1251643	usd
CY2024	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	433566	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	387452	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	924538	usd
CY2024	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2635622	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5646328	usd
CY2024	dei	Document Type DocumentType	20-F
CY2024	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2024	dei	Entity File Number EntityFileNumber	001-38773
CY2024	dei	Entity Registrant Name EntityRegistrantName	China SXT Pharmaceuticals, Inc.
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	D8
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	178 Taidong Rd North
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	Taizhou
CY2024	dei	Entity Address Country EntityAddressCountry	CN
CY2024	dei	Security12b Title Security12bTitle	Ordinary shares, no par value each
CY2024	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	0	shares
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2024	dei	Auditor Firm AuditorFirmId	6413
CY2024	dei	Auditor Name AuditorName	ZH CPA, LLC
CY2024	dei	Auditor Location AuditorLocation	Denver, Colorado
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12070345	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17368478	usd
CY2024Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	6842	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1314781	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1344569	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	794855	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	531254	usd
CY2024Q1	us-gaap	Supplies Supplies	14902	usd
CY2023Q1	us-gaap	Supplies Supplies	46304	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	31634	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	230642	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	14233359	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	19521247	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	328845	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	962214	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	19101	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	27868	usd
CY2024Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8309904	usd
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8736677	usd
CY2024Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	8893698	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	10032809	usd
CY2024Q1	us-gaap	Assets Assets	23127057	usd
CY2023Q1	us-gaap	Assets Assets	29554056	usd
CY2024Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	493054	usd
CY2023Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	167453	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	21329	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	7863	usd
CY2024Q1	sxtc	Shortterm Convertible Note ShorttermConvertibleNote	1780095	usd
CY2023Q1	sxtc	Shortterm Convertible Note ShorttermConvertibleNote	3157492	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1279516	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1377850	usd
CY2024Q1	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	213571	usd
CY2023Q1	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	111951	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	187665	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	165534	usd
CY2024Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	2768413	usd
CY2023Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	3142084	usd
CY2024Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1052441	usd
CY2023Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1104860	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	8901944	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	14496938	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	117129	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5516778	usd
CY2024	us-gaap	Operating Expenses OperatingExpenses	3069188	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	6033780	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	6441316	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	-2515217	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-5607509	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-5189673	usd
CY2024	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	544279	usd
CY2023	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	476776	usd
CY2022	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	36695	usd
CY2024	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-39036	usd
CY2023	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	149513	usd
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-181581	usd
CY2024	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-583315	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-327263	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-218276	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3098532	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5934772	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5407949	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	328146	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-3098532	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-5934772	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5736095	usd
CY2024	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-828224	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-1153713	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	428356	usd
CY2024	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3926756	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7088485	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5307739	usd
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.572
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-22.23
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-137.918
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	867422	shares
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	15961407	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5736095	usd
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	2304397	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3115106	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	351537	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	428356	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	16424708	usd
CY2022	sxtc	Adoption Of Asu202006 AdoptionOfASU202006	-341619	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	16424708	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-5934772	usd
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	554571	usd
CY2023	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	3194827	usd
CY2023	sxtc	Adjustments To Additional Paid In Capital Shares Subscribed AdjustmentsToAdditionalPaidInCapitalSharesSubscribed	-1000000	usd
CY2023	sxtc	Stock Issued During Period Value Issuance Of Shares For Convertible Note Principal And Interest Partial Settlement StockIssuedDuringPeriodValueIssuanceOfSharesForConvertibleNotePrincipalAndInterestPartialSettlement	2947293	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1153713	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	14691295	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-3098532	usd
CY2024	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	352100	usd
CY2024	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	2813807	usd
CY2024	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-828224	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	13930446	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-3098532	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-5934772	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5736095	usd
CY2024	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	203247	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	250162	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	320007	usd
CY2024	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	283234	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2875694	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	477299	usd
CY2024	us-gaap	Inventory Write Down InventoryWriteDown	-72057	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	53365	usd
CY2024	us-gaap	Asset Impairment Charges AssetImpairmentCharges	401995	usd
CY2024	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	20929	usd
CY2023	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	349390	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	328146	usd
CY2024	sxtc	Convertible Note Accretion Of Financing Cost ConvertibleNoteAccretionOfFinancingCost	-292771	usd
CY2023	sxtc	Convertible Note Accretion Of Financing Cost ConvertibleNoteAccretionOfFinancingCost	-335654	usd
CY2022	sxtc	Convertible Note Accretion Of Financing Cost ConvertibleNoteAccretionOfFinancingCost	-29926	usd
CY2022	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	558186	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	352100	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	554571	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2334397	usd
CY2024	sxtc	Non Cash Operating Lease Expense NonCashOperatingLeaseExpense	69819	usd
CY2023	sxtc	Non Cash Operating Lease Expense NonCashOperatingLeaseExpense	73034	usd
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	321422	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-912947	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-831473	usd
CY2023	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	-32854	usd
CY2022	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	35073	usd
CY2024	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	219646	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-408951	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	180797	usd
CY2024	us-gaap	Increase Decrease In Prepaid Supplies IncreaseDecreaseInPrepaidSupplies	-29356	usd
CY2023	us-gaap	Increase Decrease In Prepaid Supplies IncreaseDecreaseInPrepaidSupplies	-138	usd
CY2022	us-gaap	Increase Decrease In Prepaid Supplies IncreaseDecreaseInPrepaidSupplies	-480920	usd
CY2024	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-143175	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-50313	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1023791	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-29254	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	9700	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-22792	usd
CY2024	sxtc	Increase Decrease In Refund Liabilities IncreaseDecreaseInRefundLiabilities	107883	usd
CY2023	sxtc	Increase Decrease In Refund Liabilities IncreaseDecreaseInRefundLiabilities	-1380	usd
CY2022	sxtc	Increase Decrease In Refund Liabilities IncreaseDecreaseInRefundLiabilities	-360860	usd
CY2024	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	30441	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	94339	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-186399	usd
CY2024	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	1562	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	27055	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-32000	usd
CY2024	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-69819	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-73034	usd
CY2024	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-53835	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-46373	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	384799	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1928053	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-80757	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	268293	usd
CY2024	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	7063	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	70684	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	60932	usd
CY2022	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	1558	usd
CY2024	us-gaap	Proceeds From Limited Partnership Investments ProceedsFromLimitedPartnershipInvestments	33486	usd
CY2023	us-gaap	Proceeds From Limited Partnership Investments ProceedsFromLimitedPartnershipInvestments	58381	usd
CY2022	us-gaap	Proceeds From Limited Partnership Investments ProceedsFromLimitedPartnershipInvestments	15581	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	26423	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12303	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-46909	usd
CY2024	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	433927	usd
CY2023	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	309417	usd
CY2024	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	78654	usd
CY2023	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	26106	usd
CY2022	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	33055	usd
CY2024	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	2205254	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	628911	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	3581746	usd
CY2024	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-1727418	usd
CY2023	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-2197555	usd
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-231722	usd
CY2022	sxtc	Cash Paid Related To Equity Incentive Plan CashPaidRelatedToEquityIncentivePlan	30000	usd
CY2024	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1063333	usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	3721667	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	2804848	usd
CY2024	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	110362	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	431737	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	448291	usd
CY2023	sxtc	Net Proceeds From Shares Purchase Agreements NetProceedsFromSharesPurchaseAgreements	2194827	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	3115106	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2624428	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2941602	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1595140	usd
CY2024	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-765233	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-1049683	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	394120	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5291291	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1798859	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2210644	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17368478	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15569619	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13358975	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12077187	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17368478	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15569619	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	16733	usd
CY2024	us-gaap	Interest Paid Net InterestPaidNet	24533	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	13047	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	3197	usd
CY2024	sxtc	Issuance Of Shares For Convertible Notes Principal And Interest Partial Settlement IssuanceOfSharesForConvertibleNotesPrincipalAndInterestPartialSettlement	2813807	usd
CY2023	sxtc	Issuance Of Shares For Convertible Notes Principal And Interest Partial Settlement IssuanceOfSharesForConvertibleNotesPrincipalAndInterestPartialSettlement	2947293	usd
CY2024	sxtc	Noncash Settlement Between Balances Of Accounts Receivable And Due To Related Parties NoncashSettlementBetweenBalancesOfAccountsReceivableAndDueToRelatedParties	1235290	usd
CY2023	sxtc	Noncash Settlement Between Balances Of Accounts Receivable And Due To Related Parties NoncashSettlementBetweenBalancesOfAccountsReceivableAndDueToRelatedParties	1263993	usd
CY2024	sxtc	Noncash Settlement Between Balances Of Due From Related Parties And Due To Related Parties NoncashSettlementBetweenBalancesOfDueFromRelatedPartiesAndDueToRelatedParties	6080971	usd
CY2023	sxtc	Noncash Settlement Between Balances Of Due From Related Parties And Due To Related Parties NoncashSettlementBetweenBalancesOfDueFromRelatedPartiesAndDueToRelatedParties	4051569	usd
CY2022	sxtc	Noncash Settlement Between Balances Of Due From Related Parties And Due To Related Parties NoncashSettlementBetweenBalancesOfDueFromRelatedPartiesAndDueToRelatedParties	3653418	usd
CY2023	sxtc	Equity Portion Opening Adjustment For Adoption Of Asu EquityPortionOpeningAdjustmentForAdoptionOfASU	-341619	usd
CY2023	sxtc	Right Of Use Assets Obtained In Exchange For New Operating Lease Liabilities RightOfUseAssetsObtainedInExchangeForNewOperatingLeaseLiabilities	361935	usd
CY2021Q1	sxtc	Shares Hold Collectively SharesHoldCollectively	1	pure
CY2024Q1	sxtc	Shares Hold Collectively SharesHoldCollectively	1	pure
CY2024Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	10
CY2024Q1	sxtc	Foreign Currency Translation Adjustments Balance Sheet ForeignCurrencyTranslationAdjustmentsBalanceSheet	7.2203	pure
CY2023Q1	sxtc	Foreign Currency Translation Adjustments Balance Sheet ForeignCurrencyTranslationAdjustmentsBalanceSheet	6.8676	pure
CY2022Q1	sxtc	Foreign Currency Translation Adjustments Balance Sheet ForeignCurrencyTranslationAdjustmentsBalanceSheet	6.3393	pure
CY2024Q1	sxtc	Foreign Currency Translation Adjustments Of Income And Comprehensive Income ForeignCurrencyTranslationAdjustmentsOfIncomeAndComprehensiveIncome	7.1671	pure
CY2023Q1	sxtc	Foreign Currency Translation Adjustments Of Income And Comprehensive Income ForeignCurrencyTranslationAdjustmentsOfIncomeAndComprehensiveIncome	6.8516	pure
CY2022Q1	sxtc	Foreign Currency Translation Adjustments Of Income And Comprehensive Income ForeignCurrencyTranslationAdjustmentsOfIncomeAndComprehensiveIncome	6.418	pure
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. On an ongoing basis, management reviews these estimates and assumptions using the currently available information.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Changes in facts and circumstances may cause the Company to revise its estimates. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. The following are some of the areas requiring significant judgments and estimates as of March 31, 2024 and 2023: determinations of the useful lives of long-lived assets, estimates of expected credit loss for accounts receivable and other receivables, estimates of inventory provision, sales return rate, abnormal capacity for inventory production, valuation assumptions in performing asset impairment tests of long-lived assets, the discount rate used for right-of-use assets and lease liabilities calculation, and determinations of fair value of convertible notes (liability component, etc.) and warrants. </p>
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-3098532	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-5934772	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5736095	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24711665	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-21613133	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1928053	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-80757	usd
CY2024Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	6842	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1731517	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1522739	usd
CY2024Q1	us-gaap	Inventory Adjustments InventoryAdjustments	79549	usd
CY2023Q1	us-gaap	Inventory Adjustments InventoryAdjustments	158834	usd
CY2024	us-gaap	Asset Impairment Charges AssetImpairmentCharges	401995	usd
CY2024	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	20929	usd
CY2023	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	349390	usd
CY2024Q1	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	213571	usd
CY2023Q1	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	111951	usd
CY2024Q1	sxtc	Customer Advance Current CustomerAdvanceCurrent	187665	usd
CY2023Q1	sxtc	Customer Advance Current CustomerAdvanceCurrent	165534	usd
CY2024	us-gaap	Advertising Expense AdvertisingExpense	327208	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	227850	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1025795	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-197571	usd
CY2024	us-gaap	Variable Interest Entity Ownership Percentage VariableInterestEntityOwnershipPercentage	0.10	pure
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12070345	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17368478	usd
CY2024Q1	us-gaap	Accounts Receivable Gross AccountsReceivableGross	3046298	usd
CY2023Q1	us-gaap	Accounts Receivable Gross AccountsReceivableGross	2867308	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1731517	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1522739	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1314781	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1344569	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1522739	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	762992	usd
CY2024	sxtc	Allowance For Doubtful Accounts Receivable Additional Reserve Through Expect Credit Loss AllowanceForDoubtfulAccountsReceivableAdditionalReserveThroughExpectCreditLoss	285264	usd
CY2023	sxtc	Allowance For Doubtful Accounts Receivable Additional Reserve Through Expect Credit Loss AllowanceForDoubtfulAccountsReceivableAdditionalReserveThroughExpectCreditLoss	820352	usd
CY2024	sxtc	Exchange Rate Difference ExchangeRateDifference	-76486	usd
CY2023	sxtc	Exchange Rate Difference ExchangeRateDifference	-60605	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1731517	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1522739	usd
CY2024	sxtc	Allowance For Doubtful Accounts Receivable Additional Reserve Through Expect Credit Loss AllowanceForDoubtfulAccountsReceivableAdditionalReserveThroughExpectCreditLoss	285264	usd
CY2023	sxtc	Allowance For Doubtful Accounts Receivable Additional Reserve Through Expect Credit Loss AllowanceForDoubtfulAccountsReceivableAdditionalReserveThroughExpectCreditLoss	820352	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	320722	usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	243222	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	553682	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	446866	usd
CY2024Q1	us-gaap	Inventory Adjustments InventoryAdjustments	79549	usd
CY2023Q1	us-gaap	Inventory Adjustments InventoryAdjustments	158834	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	794855	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	531254	usd
CY2024	us-gaap	Inventory Write Down InventoryWriteDown	-72057	usd
CY2024Q1	sxtc	Receivable From A Thirdparty Company ReceivableFromAThirdpartyCompany	416880	usd
CY2023Q1	sxtc	Receivable From A Thirdparty Company ReceivableFromAThirdpartyCompany	473237	usd
CY2024Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	83634	usd
CY2023Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	230642	usd
CY2024Q1	sxtc	Prepayments Receivables And Other Assets Total PrepaymentsReceivablesAndOtherAssetsTotal	500514	usd
CY2023Q1	sxtc	Prepayments Receivables And Other Assets Total PrepaymentsReceivablesAndOtherAssetsTotal	703879	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	468880	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	473237	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	31634	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	230642	usd
CY2022Q1	sxtc	Received Payments ReceivedPayments	15581	usd
CY2022Q1	sxtc	Received Payments ReceivedPayments	100000	cny
CY2021Q1	sxtc	Received Payments ReceivedPayments	3100000	usd
CY2021Q1	sxtc	Received Payments ReceivedPayments	21250000	cny
CY2023Q1	sxtc	Received Payments ReceivedPayments	58381	usd
CY2023Q1	sxtc	Received Payments ReceivedPayments	400000	cny
CY2024	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	473237	usd
CY2024	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	3250000	cny
CY2024Q1	sxtc	Received Payments ReceivedPayments	240000	cny
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2751194	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2885115	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2023316	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1922901	usd
CY2024Q1	sxtc	Impairment Provision Property Plant And Equipment ImpairmentProvisionPropertyPlantAndEquipment	399033	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	328845	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	962214	usd
CY2024	us-gaap	Depreciation Depreciation	195788	usd
CY2023	us-gaap	Depreciation Depreciation	242230	usd
CY2024	us-gaap	Asset Impairment Charges AssetImpairmentCharges	401995	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	75268	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	79134	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	56167	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	51266	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	19101	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	27868	usd
CY2024	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7459	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7932	usd
CY2024	sxtc	Long Term Amount LongTermAmount	60000000	cny
CY2018Q1	us-gaap	Area Of Land AreaOfLand	3627	sqm
CY2018Q1	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P10Y
CY2024Q1	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P10Y
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	235848	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	306050	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.054	pure
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y9M
CY2024Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	493054	usd
CY2023Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	167453	usd
CY2024Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	493054	usd
CY2023Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	167453	usd
CY2024	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	17073	usd
CY2023	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	9706	usd
CY2024Q1	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.18	pure
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	3714000	cny
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	514383	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	754000	cny
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	104428	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	54000	cny
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	7479	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	37710	cny
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	5222	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	4559710	cny
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	631512	usd
CY2023Q1	us-gaap	Cash Cash	165534	usd
CY2022Q1	us-gaap	Cash Cash	77366	usd
CY2024	sxtc	Contract With Customer Liability Prepayments From Customers ContractWithCustomerLiabilityPrepaymentsFromCustomers	49876	usd
CY2023	sxtc	Contract With Customer Liability Prepayments From Customers ContractWithCustomerLiabilityPrepaymentsFromCustomers	99746	usd
CY2024	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	19435	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	5406	usd
CY2024	sxtc	Contract With Customer Liability Exchange Rate Difference ContractWithCustomerLiabilityExchangeRateDifference	8310	usd
CY2023	sxtc	Contract With Customer Liability Exchange Rate Difference ContractWithCustomerLiabilityExchangeRateDifference	6172	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	187665	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	165534	usd
CY2024	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	19435	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	5406	usd
CY2022Q1	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	2804848	usd
CY2022Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	168291	usd
CY2022Q1	sxtc	Transaction Costs TransactionCosts	20000	usd
CY2024Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1874479	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	94384	usd
CY2024Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	1780095	usd
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	3497639	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	340147	usd
CY2023Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	3157492	usd
CY2024	us-gaap	Accretion Expense AccretionExpense	292771	usd
CY2024Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	524354	usd
CY2023	us-gaap	Accretion Expense AccretionExpense	335654	usd
CY2023Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	465936	usd
CY2024Q1	sxtc	Inventory For Product Returns InventoryForProductReturns	35719	usd
CY2023Q1	sxtc	Inventory For Product Returns InventoryForProductReturns	25962	usd
CY2024Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	968416	usd
CY2023Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	622526	usd
CY2024Q1	sxtc	Other Payable For Leasehold Improvement OtherPayableForLeaseholdImprovement	1180556	usd
CY2023Q1	sxtc	Other Payable For Leasehold Improvement OtherPayableForLeaseholdImprovement	1403258	usd
CY2024Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	257897	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	327068	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	361543	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	789232	usd
CY2024Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	2768413	usd
CY2023Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	3142084	usd
CY2024Q1	sxtc	Other Payable For Leasehold Improvement OtherPayableForLeaseholdImprovement	1180556	usd
CY2023Q1	sxtc	Other Payable For Leasehold Improvement OtherPayableForLeaseholdImprovement	1403258	usd
CY2024Q1	us-gaap	Construction Payable Current And Noncurrent ConstructionPayableCurrentAndNoncurrent	1330556	usd
CY2024Q1	us-gaap	Construction Payable Current And Noncurrent ConstructionPayableCurrentAndNoncurrent	9500000	cny
CY2024Q1	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	150000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	361543	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	789232	usd
CY2021Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	20	shares
CY2022Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	20	shares
CY2023Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	20	shares
CY2021Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	8000	usd
CY2022Q2	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	8000	usd
CY2023Q4	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	8000	usd
CY2024	us-gaap	Advertising Expense AdvertisingExpense	327208	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	227850	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	645915	usd
CY2024	sxtc	Payroll And Welfare Expenses PayrollAndWelfareExpenses	67831	usd
CY2023	sxtc	Payroll And Welfare Expenses PayrollAndWelfareExpenses	92579	usd
CY2022	sxtc	Payroll And Welfare Expenses PayrollAndWelfareExpenses	103488	usd
CY2024	us-gaap	Selling Expense SellingExpense	16176	usd
CY2023	us-gaap	Selling Expense SellingExpense	18594	usd
CY2022	us-gaap	Selling Expense SellingExpense	96954	usd
CY2024	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	22351	usd
CY2023	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	48429	usd
CY2022	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	78181	usd
CY2024	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	433566	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	387452	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	924538	usd
CY2024	us-gaap	Labor And Related Expense LaborAndRelatedExpense	828341	usd
CY2023	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1151466	usd
CY2022	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2979374	usd
CY2024	us-gaap	Professional Fees ProfessionalFees	617365	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	594727	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	555140	usd
CY2024	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	422924	usd
CY2023	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	349390	usd
CY2024	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	283234	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2875694	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	477299	usd
CY2024	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	184194	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	200717	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	367005	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	558186	usd
CY2024	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	299564	usd
CY2023	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	474334	usd
CY2022	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	579774	usd
CY2024	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2635622	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5646328	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5516778	usd
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	1	pure
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	328146	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	328146	usd
CY2024	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.15	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.15	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.15	pure
CY2024	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-3098532	usd
CY2023	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-5934772	usd
CY2022	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-5407949	usd
CY2024	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-404481	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-653066	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-811192	usd
CY2024	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	54477	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	226003	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	178293	usd
CY2024	sxtc	Income Tax Reconciliationdeductible Expense Research And Development IncomeTaxReconciliationdeductibleExpenseResearchAndDevelopment	-27629	usd
CY2023	sxtc	Income Tax Reconciliationdeductible Expense Research And Development IncomeTaxReconciliationdeductibleExpenseResearchAndDevelopment	-29497	usd
CY2022	sxtc	Income Tax Reconciliationdeductible Expense Research And Development IncomeTaxReconciliationdeductibleExpenseResearchAndDevelopment	-53415	usd
CY2024	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-1250105	usd
CY2023	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-876804	usd
CY2022	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-197693	usd
CY2024	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1250105	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	876804	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	525839	usd
CY2024	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	377633	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	456560	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	686314	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	328146	usd
CY2024Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	905574	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	552828	usd
CY2024Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	261656	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	228944	usd
CY2024Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	70854	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	71151	usd
CY2024Q1	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	12021	usd
CY2023Q1	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	23881	usd
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1250105	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	876804	usd
CY2024	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-1727418	usd
CY2023	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-2197555	usd
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-231722	usd
CY2024	sxtc	Noncash Settlement Between Balances Of Accounts Receivable And Due To Related Parties NoncashSettlementBetweenBalancesOfAccountsReceivableAndDueToRelatedParties	1235290	usd
CY2023	sxtc	Noncash Settlement Between Balances Of Accounts Receivable And Due To Related Parties NoncashSettlementBetweenBalancesOfAccountsReceivableAndDueToRelatedParties	1263993	usd
CY2024	sxtc	Noncash Settlement Between Balances Of Due From Related Parties And Due To Related Parties NoncashSettlementBetweenBalancesOfDueFromRelatedPartiesAndDueToRelatedParties	6080971	usd
CY2023	sxtc	Noncash Settlement Between Balances Of Due From Related Parties And Due To Related Parties NoncashSettlementBetweenBalancesOfDueFromRelatedPartiesAndDueToRelatedParties	4051569	usd
CY2022	sxtc	Noncash Settlement Between Balances Of Due From Related Parties And Due To Related Parties NoncashSettlementBetweenBalancesOfDueFromRelatedPartiesAndDueToRelatedParties	3653418	usd
CY2018Q1	sxtc	Right Of Use For Office And Warehouse RightOfUseForOfficeAndWarehouse	3627	sqm
CY2018Q1	us-gaap	Construction Contractor Contract Duration ConstructionContractorContractDuration	P10Y
CY2024	us-gaap	Operating Lease Expense OperatingLeaseExpense	69819	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	73034	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	77968	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent		usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
CY2023	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-137.918
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-22.230
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.572
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	266973	shares
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	867422	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41591	shares
CY2023	sxtc	Stock Issued During Period Value Share Issuance Due To Reversesplit Round Up StockIssuedDuringPeriodValueShareIssuanceDueToReversesplitRoundUp		usd
CY2024	sxtc	Stock Issued During Period Value Share Issuance Due To Reversesplit Round Up StockIssuedDuringPeriodValueShareIssuanceDueToReversesplitRoundUp		usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown		usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2022	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges		usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2024	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges		usd
CY2023	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges		usd
CY2022	sxtc	Non Cash Operating Lease Expense NonCashOperatingLeaseExpense		usd
CY2024	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables		usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
CY2024	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess		usd
CY2023	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess		usd
CY2022	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt		usd
CY2024	sxtc	Cash Paid Related To Equity Incentive Plan CashPaidRelatedToEquityIncentivePlan		usd
CY2023	sxtc	Cash Paid Related To Equity Incentive Plan CashPaidRelatedToEquityIncentivePlan		usd
CY2024	sxtc	Net Proceeds From Shares Purchase Agreements NetProceedsFromSharesPurchaseAgreements		usd
CY2022	sxtc	Net Proceeds From Shares Purchase Agreements NetProceedsFromSharesPurchaseAgreements		usd
CY2024	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2024	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	sxtc	Issuance Of Shares For Convertible Notes Principal And Interest Partial Settlement IssuanceOfSharesForConvertibleNotesPrincipalAndInterestPartialSettlement		usd
CY2022	sxtc	Noncash Settlement Between Balances Of Accounts Receivable And Due To Related Parties NoncashSettlementBetweenBalancesOfAccountsReceivableAndDueToRelatedParties		usd
CY2024	sxtc	Equity Portion Opening Adjustment For Adoption Of Asu EquityPortionOpeningAdjustmentForAdoptionOfASU		usd
CY2022	sxtc	Equity Portion Opening Adjustment For Adoption Of Asu EquityPortionOpeningAdjustmentForAdoptionOfASU		usd
CY2024	sxtc	Right Of Use Assets Obtained In Exchange For New Operating Lease Liabilities RightOfUseAssetsObtainedInExchangeForNewOperatingLeaseLiabilities		usd
CY2022	sxtc	Right Of Use Assets Obtained In Exchange For New Operating Lease Liabilities RightOfUseAssetsObtainedInExchangeForNewOperatingLeaseLiabilities		usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent		usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown		usd
CY2023Q1	sxtc	Impairment Provision Property Plant And Equipment ImpairmentProvisionPropertyPlantAndEquipment		usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2022	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate		usd
CY2024	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2024	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2024	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits		usd
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits		usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022	sxtc	Noncash Settlement Between Balances Of Accounts Receivable And Due To Related Parties NoncashSettlementBetweenBalancesOfAccountsReceivableAndDueToRelatedParties		usd
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	00000
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0001723980
CY2024	dei	No Trading Symbol Flag NoTradingSymbolFlag	true

Files In Submission

Name	View Source	Status
0001213900-24-068266-index-headers.html	Edgar Link	pending
0001213900-24-068266-index.html	Edgar Link	pending
0001213900-24-068266.txt	Edgar Link	pending
0001213900-24-068266-xbrl.zip	Edgar Link	pending
ea0210141-20f_chinasxt.htm	Edgar Link	pending
ea021014101ex1-5_chinasxt.htm	Edgar Link	pending
ea021014101ex11_chinasxt.htm	Edgar Link	pending
ea021014101ex12-1_chinasxt.htm	Edgar Link	pending
ea021014101ex12-2_chinasxt.htm	Edgar Link	pending
ea021014101ex13-1_chinasxt.htm	Edgar Link	pending
ea0210141-20f_chinasxt_htm.xml	Edgar Link	completed
ea021014101ex15-1_chinasxt.htm	Edgar Link	pending
ea021014101ex97_chinasxt.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fin_001.jpg	Edgar Link	pending
fin_002.jpg	Edgar Link	pending
fin_003.jpg	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
sxtc-20240331.xsd	Edgar Link	pending
sxtc-20240331_def.xml	Edgar Link	unprocessable
sxtc-20240331_lab.xml	Edgar Link	unprocessable
sxtc-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
sxtc-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SXTC
China SXT Pharmaceuticals, Inc. Stock $sxtc

2024 Q1 Form 20-F Financial Statement

#000121390024068266 Filed on August 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SXTC China SXT Pharmaceuticals, Inc. Stock $sxtc

2024 Q1 Form 20-F Financial Statement

#000121390024068266 Filed on August 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SXTC
China SXT Pharmaceuticals, Inc. Stock $sxtc